NuVasive, Inc. (NASDAQ:NUVA) has scheduled a conference call for 4th August 2020 at 4:30 PM Eastern Time to announce its 2Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.nuvasive.com
Earnings Expectation
NuVasive, Inc. is reporting second quarter financial results on Tuesday 4th August 2020, after market close.
According to analysts surveyed by Thomson Reuters, NUVA is expected to report 2Q20 loss of $ 0.47 per share from revenue of $ 175.79 million.
For the full year, analysts anticipate top line of $ 982.17 million, while looking forward to income of $ 0.90 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 1,215.00 million ~ $ 1,238.00 million, where as bottomline are predicted in a range of $ 2.55 ~ $ 2.65 per share
Click Here For More Historical Outlooks Of NuVasive, Inc.
NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The companys principal products include Maximum Access Surgery, a minimally disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics.
